EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study

Blair Aitken, Luke A Downey, Serah Rose, Brooke Manning, Thomas R Arkell, Brook Shiferaw, Amie C Hayley iD

Human Psychopharmacology: Clinical and Experimental · 2025

DOI: 10.1002/hup.70002 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2025. Verfasst von Blair Aitken und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Australia. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Cognition, Methylphenidate, Psychomotor Performance. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To examine the effect of a low dose (10 mg) of methylphenidate on cognitive performance, visuospatial working memory (VSWM) and gaze behaviour capabilities in healthy adults.

Methods

This randomised, double‐blind, placebo‐controlled and crossover study examined the effects of 10 mg methylphenidate on cognitive performance, VSWM and gaze behaviour. Fixation duration and rate, gaze transition entropy, and stationary gaze entropy were used to quantify visual scanning efficiency in 25 healthy adults (36% female, mean ± SD age = 33.5 ± 7.8 years, BMI = 24.1 ± 2.9 kg/m 2 ). Attention, memory, and reaction time were assessed using the E‐CogPro test battery.

Results

Methylphenidate significantly enhanced performance in numeric working memory tasks, reflected by reduced errors and increased accuracy relative to placebo. No significant changes were observed in other cognitive or visual scanning metrics.

Conclusions

A low dose of methylphenidate improves limited domains of psychomotor speed and accuracy but does not affect visual scanning efficiency. This suggests limited usefulness as a general pro‐cognitive aid and raises the possibility of a lower threshold of effect for measurable psychostimulant‐induced changes to visual scanning behaviour. Further research is needed to explore these potential dose‐response relationships and effects across diverse populations. Trial Registration ACTRN12620000499987

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System StimulantsCognitionMethylphenidatePsychomotor PerformanceAdultFemaleHumansMaleYoung AdultAttentionCross-Over StudiesDouble-Blind MethodMemory, Short-TermReaction Time

Substanzen

Central Nervous System StimulantsMethylphenidate

Autor:innen und Institutionen

  • Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Australia.
  • Institute for Breathing and Sleep (IBAS), Austin Health, Heidelberg, Australia.
  • Human Factors, Seeing Machines, Fyshwick, Australia.

ORCID-Profile: Amie C Hayley

Zitieren

APA

Aitken, B., Downey, L. A., Rose, S., Manning, B., Arkell, T. R., Shiferaw, B., & Hayley, A. C. (2025). Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.70002

Vancouver

Aitken B, Downey LA, Rose S, Manning B, Arkell TR, Shiferaw B, et al. Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study. Human Psychopharmacology: Clinical and Experimental. 2025. doi:10.1002/hup.70002

BibTeX
@article{Aitken2025,
  author = {Aitken, Blair and Downey, Luke A and Rose, Serah and Manning, Brooke and Arkell, Thomas R and Shiferaw, Brook and Hayley, Amie C},
  title = {Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2025},
  doi = {10.1002/hup.70002}
}
Kostenlos starten →